Helen McShane

Establishment of an Aerosol Challenge Model of Tuberculosis in Rhesus Macaques and an Evaluation of Endpoints for Vaccine Testing

Adrian V. S. Hill, Fergus V. Gleeson, Sally Sharpe, 2010, Clinical and Vaccine Immunology.

A new tool for tuberculosis vaccine screening: Ex vivo Mycobacterial Growth Inhibition Assay indicates BCG-mediated protection in a murine model of tuberculosis

Ann Williams, Sally Sharpe, Elena Stylianou, 2016, BMC Infectious Diseases.

Intracellular Cytokine Staining and Flow Cytometry: Considerations for Application in Clinical Trials of Novel Tuberculosis Vaccines

Tom H. M. Ottenhoff, Hazel M. Dockrell, F. Mascart, 2015, PloS one.

Enhancing the Biological Relevance of Machine Learning Classifiers for Reverse Vaccinology

Mahesan Niranjan, Yawwani Gunawardana, Ann Williams, 2017, International journal of molecular sciences.

Immunological Outcomes of New Tuberculosis Vaccine Trials: WHO Panel Recommendations

H. Dockrell, T. Ottenhoff, W. Hanekom, 2008, PLoS medicine.

Identification of Major Factors Influencing ELISpot-Based Monitoring of Cellular Responses to Antigens from Mycobacterium tuberculosis

Tom H. M. Ottenhoff, Hazel M. Dockrell, F. Mascart, 2009, PloS one.

Lessons learnt from the first efficacy trial of a new infant tuberculosis vaccine since BCG

Thomas Scriba, R. Walker, S. Lockhart, 2013, Tuberculosis.